Financials

News Discussions Technicals Forecast Seasonals

0QN1 fundamentals

Overview Statements Statistics Dividends Earnings Revenue

An in-depth look to SANTHERA PHARMACEUTICALS HOLDING AG CHF0.1 (POST CONS) operating, investing, and financing activities

0QN1 free cash flow for H1 24 is -15.36 M CHF. For 2023, 0QN1 free cash flow was 47.18 M CHF and operating cash flow was 47.27 M CHF.

‪0.00‬

Cash from operating activities

Cash from investing activities

Cash from financing activities

Income statement Balance sheet Cash flow

Currency: CHF

TTM

YoY growth

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

YoY growth

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

YoY growth

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

YoY growth

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—